Advanced Therapies Manufacturing Strategy Digital 

Assess the current manufacturing landscape in the context of the COVID-19 pandemic. What are the short and long term implications for advanced therapeutics development?

July 14 - 15, 2020 | Virtual Event

Join advanced therapies stakeholders to take stock of the first half of 2020 and the short and long term implications of the ongoing COVID-19 pandemic. Hear an update on FDA regulatory guidance for manufacturers, take part in a virtual Q&A, and gain insight on current consortia initiatives and priorities for cell and gene therapy manufacturing and commercial development.


Create New Relationships that Deliver the Highest Value for your Current Networking Needs with:


LIVE event. No pre-recorded sessions


Social: Real-time Q&A between speakers and attendees during sessions, live polling, and direct messaging capability between attendees


Enhanced Networking: automated matchmaking suggestions based on your goals & interests. Use our virtual “meeting rooms” and set up 1:1 meetings.


Breakout networking rooms and room “hopping” capability

Brand Advisory Board

speaker name

Laurie Smaldone
NDA Group
speaker name
John Balchunus
Workforce Director
National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
speaker name

Vera Hoffman
CEO & Co Founder
Reveal Pharma
speaker name
John McShane
Managing Director
speaker name
Anton Xavier
Founder and CEO
K9 Biotech
speaker name
James Zanewicz
Chief Business Officer
Tulane University